Indian Pharma in need of a Digital Pill
First-of-its-kind study ranks 40 pharma companies in India on their digital health
22 July 2015
New Delhi, July 22: Most pharmaceutical companies in India – both multi-nationals as
well as domestic – are still shying away from leveraging the huge opportunities that exist
on the digital platforms, a new study released by D Yellow Elephant
(www.dyellowelephant.com) on Wednesday revealed.
- Only 9 out of 40 companies managed a score above 50 out of 100
- LinkedIn is most popular social media platform, but only 14 companies are active
- Google+ has a high presence of 87%, but only 1 out of 40 companies is active
- Only 8 companies have an India specific Facebook page
- - Twitter showcases 52% active engagements (India and Global handles)
- Only 12 companies have a Blogger presence
- Platforms like Slideshare, Instagram and Vine are used by less than 20% rate lower than 20%
Titled ‘Indian Pharma Digital Health Report 2015’, this first-of-its-kind report analyzed as many as 40 pharmaceutical companies in India across 10 key digital parameters, ranging across websites, apps and 10 social media platforms, namely Twitter, Facebook, LinkedIn, YouTube, Google+, Instagram, Pinterest, Vine, Slideshare and Blogger.
The report has segregated all firms in key buckets of Digital Primes, Aspirants and Onlookers basis analyzes of presence, engagement, response, and consumer followership among few key parameters.
According to Mr. Aman Gupta, Managing Director of D Yellow Elephant, “The Pharmaceutical sector in India, whether Indian companies or global players, they are atleast 5-7 years lagging behing there global counterparts and if compared to other sectors, the time lag could go upto 10 years and above. Ironically, some of these same companies abroad are seen to be proactively using digital platforms to engage with health care professionals (HCPs) and patients,” he said, explaining that this report is an attempt to help the pharmaceutical sector entities in India catch up on the time gap, identify the loopholes and help them incorporate digital
medium in part of the decision making process.
Highlighting the key findings of the report, Ms. Chandni Dalal, Lead, Digital Strategy at D Yellow Elephant said, “Out of 40 companies surveyed, only 9 companies managed a score above 50 over a scale of 100 points. This shows the reluctance to effectively engage with their stakeholders on the digital platform.”
“The report is an attempt to underline the opportunities that exist and draw a roadmap for these pharmaceutical companies in India to engage better with the HCPs, and the patient community,” she said, that with the advent of smartphones across geographies, it is high time that the potential is realized. “What better way than effectively use these platforms to bridge the gap to healthcare access in a country like ours,” she explained.
According to Ms. Dalal, “Some of the results have been predictive with LinkedIn emerging as the most popular social media platform, with 95% presence; but only about 14 companies showing an active engagement. For their part, pharmaceutical companies in India are venturing on the digital highway, but basic building blocks like having an India specific website is still amiss.” About 30% of the companies still do not have an India Centric website.
In the age of quantified self, Indian patients and HCPs are exhibiting an expectations market, with the advent of digital health, big data and dialogue exchange; Indian pharma has long stayed behind the curve on social media.
The full report can be downloaded from www.dyellowelephant.com
About D Yellow Elephant:
D Yellow Elephant is a digital firm, focusing on the Pharmaceutical and Life-sciences industry offering specialized marketing communications services by integrating technology, medical sciences and communications. With a global footprint in key locations of Delhi, Mumbai, Singapore, London and New York, the firm comes with a deep understanding of the Pharmaceuticals and Healthcare market, offering specialized services in HCP engagements, consumer communications and sales force empowerment. D Yellow Elephant offers cutting-edge technical and development services like Holograms, virtual reality, gamification platforms, touch less interactions
and app developments.
D Yellow Elephant, launched in India
Specialised Digital firm for Pharmaceuticals and Healthcare
31st March 2015
New Delhi/Mumbai: ‘D Yellow Elephant’ (www.dyellowelephant.com), a full service digital agency with a focus on pharmaceutical and healthcare industry initiated its India operations today. Led by a team with extensive experience in the Pharmaceuticals and Healthcare industry, ‘D Yellow Elephant’s’ mission is to create meaningful and measurable interactive web marketing for the world’s largest health & pharma brands and corporate.
The new firm counts 3 offices and approximately 20 staffers across the globe with operations in the United States, Europe and Asia.
- D Yellow Elephant fulfills the need for specialized digital firm focused on the Pharmaceuticals and Healthcare sector.
- Formed by a team armed with 2 decades of pharmaceutical experience, a team that understands the sensitivity of the industry
- Patients are increasingly harnessing the Internet to gain knowledge about health conditions and even self-diagnose, leading to a more empowered health consumer and more informed patient-physician conversations, in this new age of participatory medicine, pharmaceutical companies must start by understanding what health communities want and then use digital technologies to reach them with information that meets the demand and takes into account applicable regulations in their markets.
The creation of D Yellow Elephant was spurred by the desire of the Aman Gupta, Co-Founder and one of the most respected names in pharmaceutical marketing, to build a truly global and integrated digital firm focused on delivering groundbreaking work in the Pharmaceuticals and Healthcare sector.
“D Yellow Elephant is an interaction firm, not a communication firm,” Said Aman Gupta.
He further added, “We have been the experts in Healthcare communications for more than 2 decades now and while digital communications have always been a part of overall structure, a need was felt to leverage our best capabilities through a medium which is bound to bring change in the coming future. D Yellow Elephant was created to respond to the need of specialized firm catering to Pharmaceuticals sector and fill in the gap with expert led, digitally oriented marketing ideas. With D Yellow Elephant, we can address not just advertising, but all points where consumers and brands come together, no matter what the channel or platform”
The firm spent a full year aligning the global services structure, company cultures and delivery model.
D Yellow Elephant develops solutions across a full range of digital media including mobile, web, television, out-of home, tablet, touch, online advertising and social media, bringing together technology and creativity in new ways that drive business growth and consumer interest.
About D Yellow Elephant:
D Yellow Elephant is a Full service Digital firm, with a specialized focus on Pharmaceutical and Healthcare Industry. The firm service offerings are spread across key verticals of Web Strategy, Design, Development and Information. D Yellow Elephant is focused on addressing the need for expert led healthcare communications designed to go beyond the traditional conventions to help engage the audience in a long lasting manner. Headquartered in India, with key offices in US and Singapore, D Yellow Elephant helps Pharma go beyond the Pill, with the Go Digital Philosophy.
For more information please contact: sonal@Dyellowelephant.com
Download Press Release in PDF